252
Views
29
CrossRef citations to date
0
Altmetric
LetterToEditor

Non‐complementaemic urticarial vasculitis: successful treatment with the IL‐1 receptor antagonist, anakinra

, , &
Pages 236-237 | Accepted 26 Jul 2006, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kyle Tegtmeyer, Giancarlo Atassi, Jeffrey Zhao, Nolan J. Maloney & Peter A. Lio. (2022) Off-Label studies on anakinra in dermatology: a review. Journal of Dermatological Treatment 33:1, pages 73-86.
Read now

Articles from other publishers (28)

Ruth X. Wang & Sabrina A. Newman. (2024) Urticarial Vasculitis. Immunology and Allergy Clinics of North America.
Crossref
Karoline Krause & Clive E. H. Grattan. 2024. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 7 .
Zhenrui Shi, Yu-ping Zhang, Dan Hong, Xiaonan Qiu, Lin Zheng, Lijuan Bian, Fengqiu Hu, Liuyu Chen, Hui Xiong, Qiongqiong Yang, Shanping Jiang, Guozhen Tan & Liangchun Wang. (2022) Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosus. International Immunopharmacology 112, pages 109197.
Crossref
E. L. Nasonov & M. Yu. Samsonov. (2022) The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist). Rheumatology Science and Practice 60:3, pages 280-298.
Crossref
Belinda S. Hall, Louise Tzung-Harn Hsieh, Sandra Sacre & Rachel E. Simmonds. (2022) The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer. Frontiers in Immunology 12.
Crossref
Stephanie L. Gu & Joseph L. Jorizzo. (2021) Urticarial vasculitis. International Journal of Women's Dermatology 7:3, pages 290-297.
Crossref
Silvia Stefania, Ripalta Colia, Rotondo Cinzia, Addolorata Corrado & Francesco Paolo Cantatore. (2021) Off-label use of anti-IL-1 drugs in rheumatic diseases. International Journal of Immunopathology and Pharmacology 35, pages 205873842110065.
Crossref
Mario Sánchez-Borges, Sandra González Díaz, Jose Antonio Ortega-Martell, Maria Isabel Rojo & Ignacio J. Ansotegui. (2020) Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria. Immunology and Allergy Clinics of North America 40:4, pages 609-623.
Crossref
Joyce C. Chang & Pamela F. Weiss. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology 1865 1890 .
Thomas Bettuzzi, Alban Deroux, Marie Jachiet, Meryem-Maud Farhat, julien wipff, Marc Fabre, Laurence Bouillet, Nora Kramkimel, Selim Aractingi, Nicolas Dupin & Benjamin Terrier. (2019) Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study. Annals of the Rheumatic Diseases 78:10, pages 1446-1448.
Crossref
Pavel Kolkhir, Maria Grakhova, Hanna Bonnekoh, Karoline Krause & Marcus Maurer. (2019) Treatment of urticarial vasculitis: A systematic review. Journal of Allergy and Clinical Immunology 143:2, pages 458-466.
Crossref
Baris Afsar, Adrian Covic, Alberto Ortiz, Rengin Elsurer Afsar & Mehmet Kanbay. (2018) The Future of IL-1 Targeting in Kidney Disease. Drugs 78:11, pages 1073-1083.
Crossref
Erol Koç, Berna Aksoy & Aslı Tatlıparmak. 2017. A Comprehensive Review of Urticaria and Angioedema. A Comprehensive Review of Urticaria and Angioedema.
James M. Fernandez, Anthony P. Fernandez & David M. Lang. (2017) Biologic Therapy in the Treatment of Chronic Skin Disorders. Immunology and Allergy Clinics of North America 37:2, pages 315-327.
Crossref
J. Foerster. (2017) Rare diseases and costly treatments: the role of IL‐1β in pustular psoriasis. British Journal of Dermatology 176:1, pages 17-18.
Crossref
Durga Prasanna Misra & Sajjan N. Shenoy. (2016) Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatology International 37:1, pages 151-167.
Crossref
Elena Borzova & Clive E. H. Grattan. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 6 .
Javier Loricera, Ricardo Blanco, José L. Hernández, Trinitario Pina, M. Carmen González-Vela & Miguel A. González-Gay. (2015) Biologic therapy in ANCA-negative vasculitis. International Immunopharmacology 27:2, pages 213-219.
Crossref
Giulio Cavalli & Charles A. Dinarello. (2015) Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology, pages kev269.
Crossref
Jonathan A. Bernstein, David M. Lang, David A. Khan, Timothy Craig, David Dreyfus, Fred Hsieh, Javed Sheikh, David Weldon, Bruce Zuraw, David I. Bernstein, Joann Blessing-Moore, Linda Cox, Richard A. Nicklas, John Oppenheimer, Jay M. Portnoy, Christopher R. Randolph, Diane E. Schuller, Sheldon L. Spector, Stephen A. Tilles & Dana Wallace. (2014) The diagnosis and management of acute and chronic urticaria: 2014 update. Journal of Allergy and Clinical Immunology 133:5, pages 1270-1277.e66.
Crossref
Karoline Krause, Aos Mahamed, Karsten Weller, Martin Metz, Torsten Zuberbier & Marcus Maurer. (2013) Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study. Journal of Allergy and Clinical Immunology 132:3, pages 751-754.e5.
Crossref
Erynn M Boyer, Martin Turman & Kathleen M O'Neil. (2011) Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report. Pediatric Rheumatology 9:1.
Crossref
Heather A. Brandling‐Bennett & Marilyn G. Liang. 2011. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology.
Charles A. Dinarello. (2011) A clinical perspective of IL‐1β as the gatekeeper of inflammation. European Journal of Immunology 41:5, pages 1203-1217.
Crossref
I. Kötter & G. Horneff. (2010) IL-1-AntagonistenIL-1 antagonists. Zeitschrift für Rheumatologie 69:7, pages 581-593.
Crossref
Charles A. Dinarello. (2010) Why not treat human cancer with interleukin-1 blockade?. Cancer and Metastasis Reviews 29:2, pages 317-329.
Crossref
Anna Peroni, Chiara Colato, Giovanna Zanoni & Giampiero Girolomoni. (2010) Urticarial lesions: If not urticaria, what else? The differential diagnosis of urticaria. Journal of the American Academy of Dermatology 62:4, pages 557-570.
Crossref
Matt Morgan & David A. Khan. (2008) Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Annals of Allergy, Asthma & Immunology 100:6, pages 517-526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.